Icahn Accuses Forest Laboratories, Inc. of Hiding Poison Pill Agreements
Published: Aug 10, 2012
Activist investor Carl Icahn, engaged in a bitter proxy battle with Forest Laboratories Inc, accused the drugmaker of hiding information from shareholders that might show it has built provisions into its licensing agreements that would deter a potential suitor. Icahn said on Friday he had asked a Delaware court to allow him to release non-public information to shareholders that he believes would shed light on the matter. Forest has refused to release documents that would answer the question, but a court agreed recently to allow Icahn to see them.